De Aller-Bedste Bøger - over 12 mio. danske og engelske bøger
Levering: 1 - 2 hverdage
Hjælp
Login
  1. Forside
  2. Bøger
  3. Rare Cancer Agenda 2030

Rare Cancer Agenda 2030

af Europe Rare Cancers Europe
Rare Cancer Agenda 2030 af Europe Rare Cancers Europe
Bag om Rare Cancer Agenda 2030

RARE CANCER AGENDA 2030 Ten Recommendations from the EU Joint Action on Rare Cancers 1. Rare cancers are the rare diseases of oncology 2. Rare cancers should be monitored 3. Health systems should exploit networking 4. Medical education should exploit and serve healthcare networking 5. Research should be fostered by networking and should take into account an expected higher degree of uncertainty 6. Patient-physician shared clinical decision-making should be especially valued 7. Appropriate state-of-the-art instruments should be developed in rare cancer 8. Regulation on rare cancers should tolerate a higher degree of uncertainty 9. Policy strategies on rare cancers and sustainability of interventions should be based on networking 10. Rare cancer patients should be engaged

Vis mere
  • Sprog:
  • Engelsk
  • ISBN:
  • 9788831637282
  • Indbinding:
  • Paperback
  • Sideantal:
  • 132
  • Udgivet:
  • 12. december 2019
  • Vægt:
  • 160 g.
  • 2-3 uger.
  • 17. december 2024
Forlænget returret til d. 31. januar 2025

Normalpris

Abonnementspris

- Rabat på køb af fysiske bøger
- 1 valgfrit digitalt ugeblad
- 20 timers lytning og læsning
- Adgang til 70.000+ titler
- Ingen binding

Abonnementet koster 75 kr./md.
Ingen binding og kan opsiges når som helst.

Bag om Europe Rare Cancers Europe

Vis alle bøger af Europe Rare Cancers Europe

Beskrivelse af Rare Cancer Agenda 2030

RARE CANCER AGENDA 2030
Ten Recommendations from the EU Joint Action on Rare Cancers
1. Rare cancers are the rare diseases of oncology
2. Rare cancers should be monitored
3. Health systems should exploit networking
4. Medical education should exploit and serve healthcare networking
5. Research should be fostered by networking and should take into
account an expected higher degree of uncertainty
6. Patient-physician shared clinical decision-making should be
especially valued
7. Appropriate state-of-the-art instruments should be developed in
rare cancer
8. Regulation on rare cancers should tolerate a higher degree of
uncertainty
9. Policy strategies on rare cancers and sustainability of interventions
should be based on networking
10. Rare cancer patients should be engaged

Brugerbedømmelser af Rare Cancer Agenda 2030



Andre købte også..